CLINICAL_TRIALS
trial_result
· 2023-12-12
Clinical Trial Update: Palbociclib After CDK and Endocrine Therapy (PACE) [Phase 2]
Summary
Phase 2 trial update of Palbociclib for metastatic breast cancer after CDK and endocrine therapy. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-12-12